期刊文献+

血清胰淀素、ADMA水平与代谢综合征的相关性

Correlation among serum levels of amylin,ADMA and metabolic syndrome
下载PDF
导出
摘要 测定代谢综合征(MS)患者血清胰淀素和非对称二甲醛精氨酸(ADMA)水平,探讨两者的相关性及二者对MS的影响。方法:70例患者和体检对象根据其存在MS组分的个数分为非MS组(MS组分0~1个,20例)、MS高危组(MS组分2个,23例)和MS组(MS组分〉2个,27例)。分别测定空腹血糖、血脂、胰岛素、腰臀比(WHR)、体重指数(BMI)等指标,同时测定血清胰淀素、ADMA的水平。结果:与非MS组比较,MS高危组,MS组血清胰淀素[(0.41±0.04)g/L比(0.46±0.06)g/L比(0.49±0.06)g/L]、ADMA[(1.28±0.06)μg/L比(1.46±0.07)μg/L比(1.51±0.08)μg/L]的水平明显升高(P〈0.05),且MS组明显高于MS高危组(P均〈0.05)。Pearson相关分析表明,血清胰淀素与甘油三酯(TG)、空腹胰岛素(FINS)、BMI、WHR、胰岛素抵抗指数(IRI)、ADMA呈正相关性(r=0.441~0.563,P均〈0.05);与高密度脂蛋白胆固醇(HDL-C)呈负相关(r=-0.461,P〈0.05);ADMA与IRI、BMI、FINS呈正相关(r=0.445~0.483,P〈0.05)。Logistic回归分析显示胰淀素、BMI、ADMA、IRI是MS的独立危险因素(OR=5.573~7.169,P均〈0.05)。结论:血清胰淀素和非对称二甲醛精氨酸的表达与代谢综合征的发生有关,两者都是MS的独立危险因素。 Objective:To examine levels of serum amylin and asymmetric dimethylarginine(ADMA)in patients with metabolic syndrome(MS),explore their correlation related with MS.Methods:According to number of MS components,a total of 70subjects were divided into non-MS group(MS components 0-1,n=20),MS high risk group(MS components 2,n=23)and MS group(MS components>2,n=27).Fasting plasma glucose,blood lipid,insulin,waist hip ratio(WHR),body mass index(BMI),serum levels of amylin and ADMA were measured.Results: Compared with non-MS group,there were significant increase in serum levels of amylin[(0.41±0.04)g/L vs.(0.46±0.06)g/L vs.(0.49±0.06)g/L]and ADMA[(1.28±0.06)μg/L vs.(1.46±0.07)μg/L vs.(1.51± 0.08)μg/L]in MS high risk group and MS group,P<0.05,and those of MS group were significantly higher than those of MS high risk group,P<0.05both.Pearson correlation analysis indicated that serum amylin was positively correlated with triglyceride(TG),fasting insulin(FINS),BMI,WHR,insulin resistance index(IRI)and ADMA(r=0.441~0.563,P<0.05all);and negatively correlated with high density lipoprotein cholesterol(HDL-C)(r =-0.461,P<0.05);ADMA was positively correlated with IRI,BMI and FINS(r=0.445~0.483,P<0.05).Logistic regression analysis indicated that amylin,BMI,ADMA and IRI were independent risk factors of MS(OR= 5.573~7.169,P<0.05all).Conclusion:Levels of serum amylin and asymmetric dimethylarginine are related to occurrence of metabolic syndrome,both of them may be independent risk factors of MS.
出处 《心血管康复医学杂志》 CAS 2013年第4期342-345,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 佳木斯大学科学技术研究项目(S2001-023)
关键词 代谢综合征X 胰淀素 非对称二甲醛精氨酸 Metabolic syndrome X Amylin Asymmetric dimethylarginine
  • 相关文献

参考文献10

  • 1Reaven GM. Relationships among insulin resistance, type 2 dia betes, essential hypertension, and cardiovascular disease: simi larities and differences [J]. J Clinical Hypertens (Greenwich) 2011, 13 (4): 238-243.
  • 2黄志宏,高燕燕.胰淀素与代谢综合征[J].国外医学(内分泌学分册),2005,25(4):246-248. 被引量:2
  • 3McLaughlin T, Stuhlinger M, Lamendola C, et al. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss [-J. J Clin En docrinol Metab, 2006, 91 (5) 1896-1900.
  • 4金文胜,潘长玉.国际糖尿病联盟关于代谢综合征定义的全球共识[J].中华内分泌代谢杂志,2005,21(4):412-413. 被引量:155
  • 5Ikeda Y, Suehiro T, Nakamura T, et al. Clinical significance of the insulin resistance index as assessed by homeostasis model as- sessment [J]. Endoer J, 2001, 48 (1): 81-86.
  • 6Fujii N, Tsuchihashi K, Sasao H, et al. Insulin resistance func- tionally limits endothelium dependent coronary vasodilation in nondiabetie patients f-J]. Heart Vessels, 2008, 23 (1): 9-15.
  • 7刘玉岚.胰淀素基础与临床研究进展[J].承德医学院学报,2008,25(2):185-187. 被引量:2
  • 8Novials A, Rodriguez-Mafias L, Chieo A, et al. Amylin and hypertension: association of an amylin-G132A gene mutation and hypertension in humans and amylin-indueed endothelium dysfunc- tion in rats [J. J Clini Endocrinol Metab, 2007, 92 (4) . 1446 -1450.
  • 9莫与京,陈东骊,陈富荣.非对称性2甲基精氨酸在心血管疾病中的应用进展[J].岭南心血管病杂志,2009,15(1):77-78. 被引量:1
  • 10Hull RL, Westermark GT, Westermark P, et al. Islet amyloid: acritical entity In the Pathogenesis o type 2diabetes I-J]. J Clin Endocrinol Metab, 2004, 89 (8) : 3629-3643.

二级参考文献61

  • 1方媛,刘治全,牟建军,贺浪冲,王嗣岑.血压盐敏感者一氧化氮系统与非对称性二甲基精氨酸和补钾的作用[J].中华高血压杂志,2006,14(10):797-801. 被引量:19
  • 2AGEWALL S. Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor [J]. Curr Vasc Phamlacol, 2003, 1 (2): 107-109.
  • 3ANTHONY S, LEIPER J, VALLANCE P. Endogenous production of nitric oxide synthase inhibitors[J ]. Vasc Med, 2005, 10 (Suppl 1):S3-S9.
  • 4MOENS A L, GOOVAERTS I, CLAEYS M J, et al. Flow- mediated vasodilation : a diagnostic instrument, or an experimental tool[J]. Chest, 2005, 127 (6): 2254-2263.
  • 5COOKE J P. Asymmetrical dimethylarginine : the Uber marker [JJ. Circulation, 2004, 109 (15): 1813-1818.
  • 6VIRDIS A, GHIADONI L, VERSARI D, et al. Endothelial function assessment in complicated hypertension [J]. Curr Pharm Des, 2008, 14 (18): 1761-1770.
  • 7ACHANV, BROADHEAD M, MALAKI M, et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase [ J ]. Arterioscler ThrombVasc Biol, 2003. 23 (8): 1455-1459.
  • 8BOGER R H, LENTZ S R, BODE-BOGER S M, et al. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst (e) inaemia in humans[J].Clin Sei (Lond), 2001, 100 (2) : 161-167.
  • 9ZSUGA J, TOROK J, MAGYAR M T, et al. Serum asymmetric dimethylarginine negatively correlates with intimamedia thickness in early-onset atherosclerosis [J].Cerebrovasc Dis, 2007, 23 (5-6): 388-394
  • 10CHIRINOS J A, DAVID R, BRALLEY J A, et al.Endogenous nitric oxide synthase inhibitors, arterial hemodvnamics, and subclinical vascular disease : the PREVENCION study[J]. Hypertension, 2008, 52 (6): 1051- 1059.

共引文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部